Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 12Gynecologic 9Lymphoid 8Gastrointestinal 7Thoracic 3Genitourinary 3Plasma cell 1

Conditions

Multiple Myeloma 19Neoplasms, Plasma Cell 4Stomach Neoplasms 1Recurrence 1Polyneuropathies 1Paraproteinemias 1Neoplasms 1Myeloproliferative Disorders 1Motor Activity 1Lung Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Endometrial Neoplasms 1Endocrine System Diseases 1Cholangiocarcinoma 1Breast Neoplasms 1Amyloidosis 1

Interventions

Dexamethasone 109pomalidomide 52Cyclophosphamide 52Bortezomib 41fludarabine phosphate 33Lenalidomide 33Peripheral Blood Stem Cell Transplantation 28carfilzomib 26Mycophenolic Acid 25Calcium Dobesilate 24daratumumab 23Cyclosporine 22Busulfan 21Antilymphocyte Serum 20Tacrolimus 19Whole-Body Irradiation 18Melphalan 17Radiotherapy 15Filgrastim 15Methotrexate 14fludarabine 12Methylprednisolone 12elotuzumab 11Cord Blood Stem Cell Transplantation 11selinexor 10ixazomib 9Etoposide 8Thalidomide 7Prednisone 7Panobinostat 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Cisplatin × Plasma cell × Clear all
NCT00083681 2010-07-02

DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse

University of Arkansas

Phase 2 Completed
180 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡